Immunocore Holdings plc

Immunocore Holdings plcverified

IMCR

Price:

$34.45

Market Cap:

$1.72B

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma,...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

IMCR

The PE Ratio as of November 2024 (TTM) for Immunocore Holdings plc (IMCR) is -31.32

According to Immunocore Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -31.32. This represents a change of -162.48% compared to the average of 50.12 of the last 4 quarters.

Immunocore Holdings plc (IMCR) Historical PE Ratio (quarterly & annually)

How has IMCR PE Ratio performed in the past?

The mean historical PE Ratio of Immunocore Holdings plc over the last ten years is -25.99. The current -31.32 PE Ratio has changed 11.95% with respect to the historical average. Over the past ten years (40 quarters), IMCR's PE Ratio was at its highest in in the September 2023 quarter at 303.44. The PE Ratio was at its lowest in in the June 2022 quarter at -54.99.

Quarterly (TTM)
Annual

Average

-25.99

Median

-13.24

Minimum

-60.41

Maximum

-8.17

Immunocore Holdings plc (IMCR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immunocore Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 540.18%

Maximum Annual PE Ratio = -8.17

Minimum Annual Increase = -39.74%

Minimum Annual PE Ratio = -60.41

Quarterly (TTM)
Annual
YearPE RatioChange
2023-60.4115.47%
2022-52.32540.18%
2021-8.17-39.74%
2020-13.5658.47%
2019-8.56-33.70%

Immunocore Holdings plc (IMCR) Average PE Ratio

How has IMCR PE Ratio performed in the past?

The current PE Ratio of Immunocore Holdings plc (IMCR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-40.30

5-year avg

-28.61

10-year avg

-25.99

Immunocore Holdings plc (IMCR) PE Ratio vs. Peers

How is IMCR’s PE Ratio compared to its peers?

Immunocore Holdings plc’s PE Ratio is greater than Arcellx, Inc. (-93.23), less than Ventyx Biosciences, Inc. (-0.95), less than Vaxcyte, Inc. (-26.20), less than DICE Therapeutics, Inc. (-23.17), greater than Nuvalent, Inc. (-35.15), less than Viridian Therapeutics, Inc. (-6.78), less than Gracell Biotechnologies Inc. (0), less than Theseus Pharmaceuticals, Inc. (-12.42), less than Monte Rosa Therapeutics, Inc. (-3.19), less than Design Therapeutics, Inc. (-5.17), less than Erasca, Inc. (-6.64), less than Mirum Pharmaceuticals, Inc. (-4.26), less than Larimar Therapeutics, Inc. (-18.42), less than KalVista Pharmaceuticals, Inc. (-7.82), less than Lyra Therapeutics, Inc. (-3.79), less than null (-0.17),

Build a custom stock screener for Immunocore Holdings plc (IMCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunocore Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunocore Holdings plc (IMCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunocore Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Immunocore Holdings plc's PE Ratio?

How is the PE Ratio calculated for Immunocore Holdings plc (IMCR)?

What is the highest PE Ratio for Immunocore Holdings plc (IMCR)?

What is the 3-year average PE Ratio for Immunocore Holdings plc (IMCR)?

What is the 5-year average PE Ratio for Immunocore Holdings plc (IMCR)?

How does the current PE Ratio for Immunocore Holdings plc (IMCR) compare to its historical average?